Eric Schoen
At a glance: Eric Schoen is CFO at Filana Therapeutics (FLNA). Their latest SEC Form 4, filed Nov 18, 2026, reported a purchase of $8K. On file: 1 purchase line ($8K) and 0 sale lines ($0).
Disclosed holdings: about $17K of FLNA stock: 31,500 shares reported on their latest Form 4 (filed Nov 18, 2026), valued at the Nov 19, 2026 close of $0.55. This counts only FLNA shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Eric Schoen's InsiderPrint
3 trades from SEC Form 4 filings, 2020 to 2026, drawn as one fingerprint.
Reading this print: Almost only buys, trading about once a year, typically $50K a trade.
- Bump outward: a purchase (3)
- Dent inward: a sale (0)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- William GoetzDirector · VSTS · 100% match
- John R. McCarthyDirector · CLMB · 100% match
- Allan DicksCFO · ONT · 99% match
- Pamela H. PatenaudeDirector · TH · 99% match
- Ravi MallelaDirector · PMTS · 99% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 18SEC | FLNAFilana Therapeutics, Inc.First buyStake +174% | Buy | 20,00031,500 held (+174%) | $0.42 | $8K | +30.3% |
- Buy
CFO Eric Schoen bought $8K of FLNA at $0.42 — first open-market purchase in our records; raises the stake by 174%.
Follow Eric Schoen
Get one email when Eric Schoen files a new purchase or sale. Free.
At most one email a day about Eric Schoen, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.